Qitai Zhao

950 total citations
31 papers, 650 citations indexed

About

Qitai Zhao is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Qitai Zhao has authored 31 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 22 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Qitai Zhao's work include Immune cells in cancer (14 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Immune Cell Function and Interaction (8 papers). Qitai Zhao is often cited by papers focused on Immune cells in cancer (14 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Immune Cell Function and Interaction (8 papers). Qitai Zhao collaborates with scholars based in China, United States and Germany. Qitai Zhao's co-authors include Yi Zhang, Guohui Qin, Feifei Ren, Lan Huang, Dan Wang, Shasha Liu, Shasha Liu, Lan Huang, Yamin Qiao and Weina Yu and has published in prestigious journals such as The Journal of Immunology, Frontiers in Immunology and Advanced Science.

In The Last Decade

Qitai Zhao

28 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qitai Zhao China 13 334 310 249 152 95 31 650
Carla Riera‐Domingo Belgium 5 325 1.0× 146 0.5× 263 1.1× 257 1.7× 95 1.0× 6 662
Kristi D. Lynn United States 7 316 0.9× 317 1.0× 368 1.5× 174 1.1× 95 1.0× 7 746
Shuo Xu China 11 184 0.6× 167 0.5× 268 1.1× 232 1.5× 75 0.8× 21 575
Mingming Yang China 9 201 0.6× 124 0.4× 264 1.1× 139 0.9× 68 0.7× 15 558
Jiemiao Hu United States 15 379 1.1× 327 1.1× 172 0.7× 46 0.3× 80 0.8× 32 657
Lelisa Gemta United States 6 394 1.2× 315 1.0× 212 0.9× 165 1.1× 59 0.6× 6 657
Heather L. Machado United States 14 282 0.8× 340 1.1× 249 1.0× 94 0.6× 44 0.5× 22 612
Yuedi Wang China 8 300 0.9× 280 0.9× 196 0.8× 83 0.5× 68 0.7× 10 573
Douglas Marvel United States 3 660 2.0× 412 1.3× 198 0.8× 65 0.4× 60 0.6× 6 836
Gaël Sugano United Kingdom 7 505 1.5× 368 1.2× 305 1.2× 131 0.9× 52 0.5× 7 784

Countries citing papers authored by Qitai Zhao

Since Specialization
Citations

This map shows the geographic impact of Qitai Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qitai Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qitai Zhao more than expected).

Fields of papers citing papers by Qitai Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qitai Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qitai Zhao. The network helps show where Qitai Zhao may publish in the future.

Co-authorship network of co-authors of Qitai Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Qitai Zhao. A scholar is included among the top collaborators of Qitai Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qitai Zhao. Qitai Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Tengyue, et al.. (2025). Single-cell transcriptomic analyses provide insights into SPP1+ TAM-mediated immune suppression and CD8+ T cell dysfunction in lung cancer. Cancer Immunology Immunotherapy. 74(10). 319–319. 1 indexed citations
2.
3.
Zhao, Zhao, Jiaqin Yan, Fang Ren, et al.. (2025). Single-cell transcriptomic analyses reveal heterogeneity and key subsets associated with survival and response to PD-1 blockade in cervical squamous cell carcinoma. Cancer Cell International. 25(1). 90–90. 1 indexed citations
4.
Wang, Shumin, Feng Li, Liubo Zhang, et al.. (2025). HMGB1 inhibits the IFN-γ–induced PD-L1 expression in NSCLC. The Journal of Immunology. 214(9). 2480–2488.
5.
Wang, Yunhan, Weina Yu, Xinxin Wang, et al.. (2025). TREM2‐Mediated Cholesterol Efflux in Macrophages Inhibits Anti‐Tumor Immunity via Limitation of CD4 + T and NK Cells. Advanced Science. 13(5). e06995–e06995. 1 indexed citations
6.
7.
Lei, Qingyang, et al.. (2024). A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis. Cancer Immunology Immunotherapy. 73(6). 108–108. 12 indexed citations
8.
Li, Aitian, et al.. (2024). A single-cell RNA-seq dataset describing macrophages in NSCLC tumor and peritumor tissues. Scientific Data. 11(1). 1064–1064. 3 indexed citations
9.
Zhang, Jingwen, et al.. (2022). BPIFB2 is highly expressed in “cold” lung adenocarcinoma and decreases T cell chemotaxis via activation of the STAT3 pathway. Molecular and Cellular Probes. 62. 101804–101804. 1 indexed citations
10.
Tian, Yonggui, Zhen Zhang, Yanfen Liu, et al.. (2022). CXCL9-modified CAR T cells improve immune cell infiltration and antitumor efficacy. Cancer Immunology Immunotherapy. 71(11). 2663–2675. 32 indexed citations
11.
Zhao, Xuan, Shasha Liu, Xinfeng Chen, et al.. (2021). L1CAM overexpression promotes tumor progression through recruitment of regulatory T cells in esophageal carcinoma. Cancer Biology and Medicine. 18(2). 547–561. 17 indexed citations
12.
13.
Li, Yang, Aitian Li, Qitai Zhao, et al.. (2021). Immune Profiling Reveals Molecular Classification and Characteristic in Urothelial Bladder Cancer. Frontiers in Cell and Developmental Biology. 9. 596484–596484. 9 indexed citations
14.
Liu, Shasha, Chaoqi Zhang, Huanyu Zhang, et al.. (2021). Regulatory T cells promote glioma cell stemness through TGF-β–NF-κB–IL6–STAT3 signaling. Cancer Immunology Immunotherapy. 70(9). 2601–2616. 71 indexed citations
15.
Hou, Lin, et al.. (2021). Indoleamine 2,3-Dioxygenase 1 Inhibitor-Loaded Nanosheets Enhance CAR-T Cell Function in Esophageal Squamous Cell Carcinoma. Frontiers in Immunology. 12. 661357–661357. 21 indexed citations
16.
Qu, Jiao, Qitai Zhao, Li Yang, et al.. (2021). Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma. International Immunopharmacology. 96. 107616–107616. 6 indexed citations
17.
Zheng, Yujia, Yu Li, Bo Tang, et al.. (2020). IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma. Cancer Immunology Immunotherapy. 69(11). 2371–2380. 41 indexed citations
18.
Sun, Ting, Qitai Zhao, Chaoqi Zhang, et al.. (2019). Screening common signaling pathways associated with drug resistance in non‐small cell lung cancer via gene expression profile analysis. Cancer Medicine. 8(6). 3059–3071. 7 indexed citations
19.
Yuan, Yongliang, Qitai Zhao, Songfeng Zhao, et al.. (2019). Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma. Cancer Medicine. 8(8). 3811–3821. 24 indexed citations
20.
Ren, Feifei, Qitai Zhao, Lan Huang, et al.. (2018). The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas. Immunology and Cell Biology. 97(5). 457–469. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla Riera‐Domingo Breakdown of academic impact, for papers by Kristi D. Lynn Breakdown of academic impact, for papers by Shuo Xu Breakdown of academic impact, for papers by Mingming Yang Breakdown of academic impact, for papers by Jiemiao Hu Breakdown of academic impact, for papers by Lelisa Gemta Breakdown of academic impact, for papers by Heather L. Machado Breakdown of academic impact, for papers by Yuedi Wang Breakdown of academic impact, for papers by Douglas Marvel Breakdown of academic impact, for papers by Gaël Sugano
Rankless by CCL
2026